vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.
Sight Sciences, Inc. is the larger business by last-quarter revenue ($20.4M vs $13.3M, roughly 1.5× Laird Superfood, Inc.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -20.4%, a 7.2% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs 6.9%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs 2.9%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.
LSF vs SGHT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $20.4M |
| Net Profit | $-1.8M | $-4.2M |
| Gross Margin | 34.1% | 87.3% |
| Operating Margin | -13.5% | -18.0% |
| Net Margin | -13.2% | -20.4% |
| Revenue YoY | 15.0% | 6.9% |
| Net Profit YoY | -341.4% | 64.9% |
| EPS (diluted) | — | $-0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $20.4M | ||
| Q3 25 | $12.9M | $19.9M | ||
| Q2 25 | $12.0M | $19.6M | ||
| Q1 25 | $11.7M | $17.5M | ||
| Q4 24 | $11.6M | $19.1M | ||
| Q3 24 | $11.8M | $20.2M | ||
| Q2 24 | $10.0M | $21.4M | ||
| Q1 24 | $9.9M | $19.3M |
| Q4 25 | $-1.8M | $-4.2M | ||
| Q3 25 | $-975.1K | $-8.2M | ||
| Q2 25 | $-362.2K | $-11.9M | ||
| Q1 25 | $-156.2K | $-14.2M | ||
| Q4 24 | $-398.4K | $-11.8M | ||
| Q3 24 | $-166.1K | $-11.1M | ||
| Q2 24 | $-239.1K | $-12.3M | ||
| Q1 24 | $-1.0M | $-16.3M |
| Q4 25 | 34.1% | 87.3% | ||
| Q3 25 | 36.5% | 86.4% | ||
| Q2 25 | 39.9% | 84.8% | ||
| Q1 25 | 41.9% | 86.2% | ||
| Q4 24 | 38.6% | 86.8% | ||
| Q3 24 | 43.0% | 83.9% | ||
| Q2 24 | 41.8% | 85.8% | ||
| Q1 24 | 40.0% | 85.5% |
| Q4 25 | -13.5% | -18.0% | ||
| Q3 25 | -7.7% | -39.7% | ||
| Q2 25 | -3.3% | -59.6% | ||
| Q1 25 | -1.9% | -79.2% | ||
| Q4 24 | -4.1% | -62.5% | ||
| Q3 24 | -2.3% | -55.7% | ||
| Q2 24 | -3.4% | -59.2% | ||
| Q1 24 | -11.0% | -76.4% |
| Q4 25 | -13.2% | -20.4% | ||
| Q3 25 | -7.6% | -41.0% | ||
| Q2 25 | -3.0% | -61.0% | ||
| Q1 25 | -1.3% | -80.8% | ||
| Q4 24 | -3.4% | -62.1% | ||
| Q3 24 | -1.4% | -54.9% | ||
| Q2 24 | -2.4% | -57.7% | ||
| Q1 24 | -10.3% | -84.4% |
| Q4 25 | — | $-0.07 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.23 | ||
| Q1 25 | — | $-0.28 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.22 | ||
| Q2 24 | — | $-0.25 | ||
| Q1 24 | — | $-0.33 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $92.0M |
| Total DebtLower is stronger | — | $42.4M |
| Stockholders' EquityBook value | $11.5M | $63.9M |
| Total Assets | $19.2M | $115.3M |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $92.0M | ||
| Q3 25 | $5.1M | $92.4M | ||
| Q2 25 | $3.9M | $101.5M | ||
| Q1 25 | $7.0M | $108.8M | ||
| Q4 24 | $8.3M | $120.4M | ||
| Q3 24 | $7.9M | $118.6M | ||
| Q2 24 | $7.6M | $118.2M | ||
| Q1 24 | $7.1M | $127.3M |
| Q4 25 | — | $42.4M | ||
| Q3 25 | — | $42.4M | ||
| Q2 25 | — | $42.4M | ||
| Q1 25 | — | $42.4M | ||
| Q4 24 | — | $40.0M | ||
| Q3 24 | — | $37.1M | ||
| Q2 24 | — | $35.0M | ||
| Q1 24 | — | $35.0M |
| Q4 25 | $11.5M | $63.9M | ||
| Q3 25 | $12.8M | $64.3M | ||
| Q2 25 | $13.4M | $70.0M | ||
| Q1 25 | $13.3M | $77.6M | ||
| Q4 24 | $13.2M | $87.5M | ||
| Q3 24 | $13.1M | $95.0M | ||
| Q2 24 | $12.6M | $101.6M | ||
| Q1 24 | $12.7M | $109.2M |
| Q4 25 | $19.2M | $115.3M | ||
| Q3 25 | $18.9M | $116.3M | ||
| Q2 25 | $20.4M | $122.0M | ||
| Q1 25 | $21.5M | $129.7M | ||
| Q4 24 | $19.3M | $142.8M | ||
| Q3 24 | $18.8M | $143.6M | ||
| Q2 24 | $18.0M | $149.7M | ||
| Q1 24 | $17.6M | $155.6M |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.66× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.55× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.34× | ||
| Q1 24 | — | 0.32× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-1.8M |
| Free Cash FlowOCF − Capex | — | $-2.0M |
| FCF MarginFCF / Revenue | — | -9.7% |
| Capex IntensityCapex / Revenue | — | 0.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-1.8M | ||
| Q3 25 | $1.2M | $-8.7M | ||
| Q2 25 | $-2.8M | $-7.5M | ||
| Q1 25 | $-1.3M | $-11.6M | ||
| Q4 24 | $339.2K | $-3.5M | ||
| Q3 24 | $305.8K | $362.0K | ||
| Q2 24 | $642.7K | $-9.5M | ||
| Q1 24 | $-422.3K | $-9.8M |
| Q4 25 | — | $-2.0M | ||
| Q3 25 | — | $-8.9M | ||
| Q2 25 | — | $-7.8M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-3.6M | ||
| Q3 24 | — | $311.0K | ||
| Q2 24 | — | $-9.5M | ||
| Q1 24 | — | $-9.9M |
| Q4 25 | — | -9.7% | ||
| Q3 25 | — | -44.7% | ||
| Q2 25 | — | -39.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -18.9% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | -44.7% | ||
| Q1 24 | — | -51.4% |
| Q4 25 | — | 0.8% | ||
| Q3 25 | — | 0.9% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.7% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | — | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
SGHT
| Surgical Glaucoma | $19.7M | 96% |
| Other | $724.0K | 4% |
